See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. While Cosentyx is generally well-tolerated, long-term side effects may occur. It is essential to discuss potential side effects with a healthcare provider.

Based on the available information, the long-term side effects associated with Cosentyx use include:

1. Infections: Cosentyx affects the immune system, which may increase the risk of infections, such as upper respiratory tract infections, urinary tract infections, and fungal infections [1][2]. Long-term use may increase the risk of severe or opportunistic infections.

2. Cancer: There is a potential increased risk of certain cancers, such as skin cancer and lymphoma, with the long-term use of immunosuppressive medications like Cosentyx [1][2]. However, the overall risk is considered low, and the benefits of treatment typically outweigh the potential risks.

3. Cardiovascular events: Although not directly mentioned in the available information, long-term use of immunosuppressive medications may increase the risk of cardiovascular events, such as heart attack and stroke [2]. Patients should discuss their cardiovascular health with their healthcare provider.

4. Allergic reactions: Although rare, some individuals may experience allergic reactions to Cosentyx, which could lead to serious side effects [1].

5. Other long-term side effects: Other long-term side effects may include decreased immune system function, liver enzyme elevations, and potential effects on fertility [1].

It is essential to consult a healthcare provider for personalized advice regarding the long-term side effects of Cosentyx, as individual risks may vary.

Sources:
[1] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) [Prescribing Information]. January 2022. Available from: <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>.
[2] DrugPatentWatch. Cosentyx (secukinumab) Drug Profile. Available from: <https://www.drugpatentwatch.com/drugs/cosentyx>.